Management of obesity in the elderly: Too much and too late?

Journal of Nutrition, Health and Aging

Volumn 12, Issue 9, 2008, Pages 608-621

  Kennedy, R Lee ^a   Malabu, U ^a   Kazi, M ^a   Shahsidhar, V ^a  

^a JAMES COOK UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ESTROGEN; GLUCOSE; GROWTH HORMONE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROCORTISONE; INTERLEUKIN 6; LEPTIN; PHENTERMINE; PRASTERONE; PROLACTIN; RIMONABANT; SEX HORMONE BINDING GLOBULIN; SIBUTRAMINE; SOMATOMEDIN C; TESTOSTERONE; TETRAHYDROLIPSTATIN; THYROID HORMONE; TRIACYLGLYCEROL; VITAMIN D;

ABDOMINAL OBESITY; ANXIETY; ARTICLE; BARIATRIC SURGERY; BODY MASS; CARDIOVASCULAR RISK; CIGARETTE SMOKING; COGNITIVE DEFECT; COLORECTAL CANCER; CONSTIPATION; DEATH; DEFECATION; DEPRESSION; DIET RESTRICTION; DIET THERAPY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DIZZINESS; ELDERLY CARE; ENDOCRINE DISEASE; FECES INCONTINENCE; FLATULENCE; GASTROESOPHAGEAL REFLUX; GLUCOSE BLOOD LEVEL; HEADACHE; HUMAN; HYPERTENSION; INSOMNIA; KINESIOTHERAPY; KNEE OSTEOARTHRITIS; LIFE EXPECTANCY; LOW CARBOHYDRATE DIET; METABOLIC SYNDROME X; NAUSEA; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; OBESITY; PERIODONTAL DISEASE; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; RETINA MACULA AGE RELATED DEGENERATION; RHINITIS; RISK ASSESSMENT; SIDE EFFECT; SLEEP APNEA SYNDROME; STEATORRHEA; WAIST CIRCUMFERENCE; WEIGHT CONTROL; XEROSTOMIA;

EID: 56749095631     PISSN: 12797707     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (222)

1. Kennedy RL, Chokkalingham K, Srinivasan R. Obesity in the elderly: who should we be treating, and why, and how? Current Opinion in Clinical Nutrition & Metabolic Care 2004;7(1):3-9.
2. McTigue KM, Hess R, Ziouras J. Obesity in older adults: a systematic review of the evidence for diagnosis and treatment. Obesity 2006;14(9):1485-97.
3. Arterburn DE, Crane PK, Sullivan SD. The coming epidemic of obesity in elderly Americans. Journal of the American Geriatrics Society 2004;52(11):1907-12.
4. Li C, Ford ES, McGuire LC, Mokdad AH. Increasing trends in waist circumference and abdominal obesity among US adults. Obesity 2007;15(1):216-24.
5. Flegal KM, Williamson DF, Pamuk ER, Rosenberg HM. Estimating deaths attributable to obesity in the United States.[see comment]. American Journal of Public Health 2004;94(9):1486-9.
6. Flegal KM, Graubard BI, Williamson DF, Gail MH. Excess deaths associated with underweight, overweight, and obesity. [see comment]. JAMA 2005;293(15):1861-7.
7. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006;295(13):1549-55.
8. Cowie CC, Rust KF, Byrd-Holt DD, Eberhardt MS, Flegal KM, Engelgau MM, et al. Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health And Nutrition Examination Survey 1999-2002. Diabetes Care 2006;29(6):1263-8.
9. Arterburn DE, Maciejewski ML, Tsevat J. Impact of morbid obesity on medical expenditures in adults. International Journal of Obesity 2005;29(3):334-9.
10. Ajani UA, Lotufo PA, Gaziano JM, Lee IM, Spelsberg A, Buring JE, et al. Body mass index and mortality among US male physicians. Annals of Epidemiology 2004; 14(10):731-9.
11. Nyholm M, Merlo J, Rastam L, Lindblad U. Overweight and all-cause mortality in a Swedish rural population: Skaraborg Hypertension and Diabetes Project. Scandinavian Journal of Public Health 2005;33(6):478-86.
12. Jee SH, Sull JW, Park J, Lee SY, Ohrr H, Guallar E, et al. Body mass index and mortality in Korean men and women. New England Journal of Medicine 2006;355(8):779-87.
13. Manini TM, Everhart JE, Patel KV, Schoeller DA, Colbert LH, Visser M, et al. Daily activity energy expenditure and mortality among older adults.[sea comment]. JAMA 2006;296(2):171-9.
14. Janssen I, Mark AE. Elevated body mass index and mortality risk in the elderly. Obesity Reviews 2007;8(1):41-59.
15. He Y, Jiang B, Wang J, Feng K, Chang Q, Fan L, et al. Prevalence of the metabolic syndrome and its relation to cardiovascular disease in an elderly Chinese population. Journal of the American College of Cardiology 2006;47(8):1588-94.
16. Maggi S, Noale M, Gallina P, Bianchi D, Marzari C, Limongi F, et al. Metabolic syndrome, diabetes, and cardiovascular disease in an elderly Caucasian cohort: the Italian Longitudinal Study on Aging. Journals of Gerontology Series A-Biological Sciences & Medical Sciences 2006;61(5):505-10.
17. Park HS, Kim SM, Lee IS, Lee J, Han JH, Yoon DY, et al. Prevalence and trends of metabolic syndrome in Korea: Korean National Health and Nutrition Survey 1998-2001. Diabetes, Obesity & Metabolism 2007;9(1):50-8.
18. Gause-Nilsson I, Gherman S, Kumar Dey D, Kennerfalk A, Steen B. Prevalence of metabolic syndrome in an elderly Swedish population. Acta Diabetologica 2006;43(4):120-6.
19. Kasai T, Miyauchi K, Kurata T, Ohta H, Okazaki S, Miyazaki T, et al. Prognostic value of the metabolic syndrome for long-term outcomes in patients undergoing percutaneous coronary intervention. Circulation Journal 2006;70(12):1531-7.
20. Cabrera MAS, Gebara OCE, Diament J, Nussbacher A, Rosano G, Wajngarten M. Metabolic syndrome, abdominal obesity, and cardiovascular risk in elderly women. International Journal of Cardiology 2007;114(2):224-9.
21. Milionis HJ, Rizos E, Goudevenos J, Seferiadis K, Mikhailidis DP, Elisaf MS. Components of the metabolic syndrome and risk for first-ever acute ischemic nonembolic stroke in elderly subjects. Stroke 2005;36(7):1372-6.
22. Golledge J, Leicht A, Crowther RG, Clancy P, Spinks WL, Quigley F. Association of obesity and metabolic syndrome with the severity and outcome of intermittent claudication. Journal of Vascular Surgery 2007;45(1):40-6.
23. Otiniano ME, Du XL, Maldonado MR, Ray L, Markides K. Effect of metabolic syndrome on heart attack and mortality in Mexican-American elderly persons: findings of 7-year follow-up from the Hispanic established population for the epidemiological study of the elderly. Journals of Gerontology Series A-Biological Sciences & Medical Sciences 2005;60(4):466-70.
24. Ravaglia G, Forti P, Maioli F, Bastagli L, Chiappelli M, Montesi F, et al. Metabolic Syndrome: prevalence and prediction of mortality in elderly individuals. Diabetes Care 2006;29(11):2471-6.
25. Lee JS, Kritchevsky SB, Tylavsky F, Harris T, Simonsick EM, Rubin SM, et al. Weight change, weight change intention, and the incidence of mobility limitation in well-functioning community-dwelling older adults. Journals of Gerontology Series A-Biological Sciences & Medical Sciences 2005;60(8):1007-12.
26. Bohannon RW, Brennan PJ, Pescatello LS, Marschke L, Hasson S, Murphy M. Adiposity of elderly women and its relationship with self-reported and observed physical performance. Journal of Geriatric Physical Therapy 2005;28(1):10-3.
27. Jensen GL. Obesity and functional decline: epidemiology and geriatric consequences. Clinics in Geriatric Medicine;21(4):677-87.
28. Lebrun CEI, van der Schouw YT, de Jong FH, Grobbee DE, Lamberts SW. Fat mass rather than muscle strength is the major determinant of physical function and disability in postmenopausal women younger than 75 years of age. Menopause 2006;13(3):474-81.
29. Cankurtaran M, Halil M, Yavuz BB, Dagli N, Oyan B, Ariogul S. Prevalence and correlates of metabolic syndrome (MS) in older adults. Archives of Gerontology & Geriatrics 2006;42(1):35-45.
30. Ramsay SE, Whincup PH, Shaper AG, Wannamethee SG. The relations of body composition and adiposity measures to ill health and physical disability in elderly men. American Journal of Epidemiology 2006;164(5):459-69.
31. Lafortuna CL, Agosti F, Proietti M, Adorni F, Sartorio A. The combined effect of adiposity, fat distribution and age on cardiovascular risk factors and motor disability in a cohort of obese women (aged 18-83). Journal of Endocrinological Investigation 2006;29(10):905-12.
32. Okoro CA, Zhong Y, Ford ES, Balluz LS, Strine TW, Mokdad AH. Association between the metabolic syndrome and its components and gait speed among U.S. adults aged 50 years and older: a cross-sectional analysis. BMC Public Health 2006;6:282.
33. Blazer DG, Hybels CF, Fillenbaum GG. Metabolic syndrome predicts mobility decline in a community-based sample of older adults. Journal of the American Geriatrics Society 2006;54(3):502-6.
34. Roriz-Cruz M, Rosser I, Wada T, Sakagami T, Ishine M, Roriz-Filho JS, et al. Stroke-independent association between metabolic syndrome and functional dependence, depression, and low quality of life in elderly community-dwelling Brazilian people. Journal of the American Geriatrics Society 2007;55(3):374-82.
35. Arterburn DE, McDonell MB, Hedrick SC, Diehr P, Fihn SD. Association of body weight with condition-specific quality of fife in male veterans. American Journal of Medicine 2004;117(10):738-46.
36. Lebrun CEI, van der Schouw YT, de Jong FH, Pols HAP, Grobbee DE, Lamberts SWJ. Relations between body composition, functional and hormonal parameters and quality of life in healthy postmenopausal women. Maturitas 2006;55(1):82-92.
37. Sach TH, Barton GR, Doherty M, Muir KR, Jenkinson C, Avery AJ. The relationship between body mass index and health-related quality of life: comparing the EQ-5D, EuroQol VAS and SF-6D. International Journal of Obesity 2007;31(1):189-96.
38. Huang IC, Frangakis C, Wu AW. The relationship of excess body weight and health-related quality of life: evidence from a population study in Taiwan. International Journal of Obesity 2006;30(8):1250-9.
39. Gregg EW, Cheng YJ, Cadwell BL, Imperatore G, Williams DE, Flegal KM, et al. Secular trends in cardiovascular disease risk factors according to body mass index in US adults.[see comment] [erratum appears in JAMA. 2005 Jul 13;294(2):182]. JAMA 2005;293(15):1868-74.
40. Noale M, Maggi S, Marzari C, Limongi F, Gallina P, Bianchi D, et al. Components of the metabolic syndrome and incidence of diabetes in elderly Italians: the Italian Longitudinal Study on Aging. Atherosclerosis 2006;187(2):385-92.
41. Onat A, Hergenc G, Turkmen S, Yazici M, Sari I, Can G. Discordance between insulin resistance and metabolic syndrome: features and associated cardiovascular risk in adults with normal glucose regulation. Metabolism: Clinical & Experimental 2006;55(4):445-52.
42. Wexler DJ, Grant RW, Wittenberg E, Bosch JL, Cagliero E, Delahanty L, et al. Correlates of health-related quality of life in type 2 diabetes. Diabetologia 2006;49(7):1489-97.
43. Wray LA, Ofstedal MB, Langa KM, Blaum CS. The effect of diabetes on disability in middle-aged and older adults. Journals of Gerontology Series A-Biological Sciences & Medical Sciences 2005;60(9):1206-11.
44. Calle EE, Rodriguez C, Walker-Thurmond K, Than MJ. Overweight, obesity and mortality from cancer in a prospectively studied cohort of US adults. New England Journal of Medicine 2003;348(17):1625-38.
45. Sedjo RL, Byers T, Levin TR, Haffner SM, Saad MF, Tooze JA, et al. Change in body size and the risk of colorectal adenornas. Cancer Epidemiology, Biomarkers & Prevention 2007;16(3):526-31.
46. Sturmer T, Buring JE, Lee IM, Gaziano JM, Glynn RJ. Metabolic abnormalities and risk for colorectal cancer in the physicians' health study. Cancer Epidemiology, Biomarkers &Prevention 2006; 15(12):2391-7.
47. Janssen I. Influence of sarcopenia on the development of physical disability: the Cardiovascular Health Study. Journal of the American Geriatrics Society 2006;54(1):56-62.
48. Jinks C, Jordan K, Croft P. Disabling knee pain--another consequence of obesity: results from a prospective cohort study. BMC Public Health 2006;6:258.
49. Reijman M, Pols HAP, Bergink AP, Hazes JMW, Belo JN, Lievense AM, et al. Body mass index associated with onset and progression of osteoarthritis of the knee but not of the hip: the Rotterdam Study. [see comment]. Annals of the Rheumatic Diseases 2007;66(2):158-62.
50. Wannamethee SG, Shaper AG, Whincup PH. Body fat distribution, body composition, and respiratory function in elderly men. American Journal of Clinical Nutrition 2005;82(5):996-1003.
51. Yende S, Waterer GW, Tolley EA, Newman AB, Bauer DC, Taaffe DR, et al. Inflammatory markers are associated with ventilatory limitation and muscle dysfunction in obstructive lung disease in well functioning elderly subjects.[see comment]. Thorax 2006;61(1):10-6.
52. Ocasio-Tascon ME, Alicea-Colon E, Torres-Palacios A, Rodriguez-Cintron W. The veteran population: one at high risk for sleep-disordered breathing. Sleep & Breathing 2006;10(2):70-5.
53. Jackson RA, Vittinghoff E, Kanaya AM, Miles TP, Resnick HE, Kritchevsky SB, et al. Urinary incontinence in elderly women: findings from the Health, Aging, and Body Composition Study. Obstetrics & Gynecology 2004;104(2):301-7.
54. Asplund R. Obesity in elderly people with nocturia: cause or consequence? Canadian Journal of Urology 2007;14(1):3424-8.
55. Rey E, Moreno-Elola-Olaso C, Artalejo FR, Locke GR, 3rd, Diaz-Rubio M. Association between weight gain and symptoms of gastroesophageal reflux in the general population. American Journal of Gastroenterology 2006;101(2):229-33.
56. Oh S-Y, Cho Y-K, Kang M-S, Yoo T-W, Park J-H, Kim H-J, et al. The association between increased alanine aminotransferase activity and metabolic factors in nonalcoholic fatty liver disease. Metabolism: Clinical & Experimental 2006;55(12):1604-9.
57. Onat A, Hergenc G, Karabulut A, Turkmen S, Doan Y, Uyarel H, et al. Serum gamma glutamyltransferase as a marker of metabolic syndrome and coronary disease likelihood in nondiabetic middle-aged and elderly adults. Preventive Medicine 2006;43(2):136-9.
58. Clark JM. Weight loss as a treatment for nonalcoholic fatty liver disease. Journal of Clinical Gastroenterology 2006;40(3 Suppl 1):S39-43.
59. Seddon JM, Cote J, Davis N, Rosner B. Progression of age-related macular degeneration: association with body mass index, waist circumference, and waist-hip ratio. Archives of Ophthalmology 2003;121(6):785-92.
60. Moeini HA, Masoudpour H, Ghanbari H. A study of the relation between body mass index and the incidence of age related macular degeneration. British Journal of Ophthalmology 2005;89(8):964-6.
61. Klein R, Deng Y, Klein BEK, Hyman L, Seddon J, Frank RN, et al. Cardiovascular disease, its risk factors and treatment, and age-related macular degeneration: Women's Health Initiative Sight Exam ancillary study. American Journal of Ophthalmology 2007;143(3):473-83.
62. Seddon JM, George S, Rosner B, Klein ML. CFH gene variant, Y402H, and smoking, body mass index, environmental associations with advanced age-related macular degeneration. Human Heredity 2006;61(3):157-65.
63. Schaumberg DA, Hankinson SE, Guo Q, Rimm E, Hunter DJ. A prospective study of 2 major age-related macular degeneration susceptibility alleles and interactions with modifiable risk factors.[see comment]. Archives of Ophthalmology 2007;125(1):55-62.
64. Seddon JM, George S, Rosner B, Rifai N. Progression of age-related macular degeneration: prospective assessment of C-reactive protein, interleukin 6, and other cardiovascular biomarkers. Archives of Ophthalmology 2005;123(6):774-82.
65. Navarro Esteban JJ, Gutierrez Leiva JA, Valerc, Caracena N, Buendia Bermejo J, Calle Puron ME, Martinez Vizcaino VJ. Prevalence and risk factors of lens opacities in the elderly in Cuenca, Spain. European Journal of Ophthalmology 2007;17(1):29-37.
66. Vanhanen M, Koivisto K, Moilanen L, Helkala EL, Hanninen T, Soininen H, et al. Association of metabolic syndrome with Alzheimer disease: a population-based study. Neurology 2006;67(5):843-7.
67. Komulainen P, Lakka TA, Kivipelto M, Hassinen M, Helkala E-L, Haapala I, et al. Metabolic syndrome and cognitive function: a population-based follow-up study in elderly women. Dementia & Geriatric Cognitive Disorders 2007;23(1):29-34.
68. Xiong GL, Plassman BL, Helms MJ, Steffens DC. Vascular risk factors and cognitive decline among elderly male twins. Neurology 2006;67(9):1586-91.
69. McGuire LC, Ford ES, Ajani UA. Cognitive functioning as a predictor of functional disability in later life. American Journal of Geriatric Psychiatry 2006;14(1):36-42.
70. Rosano C, Simonsick EM, Harris TB, Kritchevsky SB, Brach J, Visser M, et al. Association between physical and cognitive function in healthy elderly: the health, aging and body composition study. Neuroepidemiology 2005;24(1-2):8-14.
71. Gorospe EC, Dave JK. The risk of dementia with increased body mass index. Age & Ageing 2007;36(1):23-9.
72. Alexandersen P, Tanko LB, Bagger YZ, Jespersen J, Skouby SO, Christiansen C. Associations between aortic calcification and components of body composition in elderly men. Obesity 2006;14(9):1571-8.
73. Blaum CS, Xue QL, Michelon E, Semba RD, Fried LP. The association between obesity and the frailty syndrome in older women: the Women's Health and Aging Studies. [see comment]. Journal of the American Geriatrics Society 2005;53(6):927-34.
74. Woods NF, LaCroix AZ, Gray SL, Aragaki A, Cochrane BB, Brunner RL, et al. Frailty: emergence and consequences in women aged 65 and older in the Women's Health Initiative Observational Study.[see comment]. Journal of the American Geriatrics Society 2005;53(8):1321-30.
75. Baumgartner RN, Wayne SJ, Waters DL, Janssen I, Gallagher D, Morley JE. Sarcopenic obesity predicts instrumental activities of daily living disability in the elderly. Obesity Research 2004; 12(12):1995-2004.
76. Cesari M, Leeuwenburgh C, Lauretani F, Onder G, Bandinelli S, Maraldi C, et al. Frailty syndrome and skeletal muscle: results from the Invecchiare in Chianti study. American Journal of Clinical Nutrition 2006;83(5):1142-8.
77. Liu-Ambrose T, Kravetsky L, Bailey D, Sherar L, Mundt C, Baxter-Jones A, et al. Change in lean body mass is a major determinant of change in areal bone mineral density of the proximal femur: a 12-year observational study. Calcified Tissue International 2006;79(3):145-51.
78. Aubertin-Leheudre M, Lord C, Goulet EDB, Khalil A, Dionne IJ. Effect of sarcopenia on cardiovascular disease risk factors in obese postmenopausal women. Obesity 2006;14(12):2277-83.
79. Katsiaras A, Newman AB, Kriska A, Brach J, Krishnaswami S, Feingold E, et al. Skeletal muscle fatigue, strength, and quality in the elderly: the Health ABC Study. Journal of Applied Physiology 2005;99(1):210-6.
80. Goodpaster BH, Park SW, Harris TB, Kritchevsky SB, Nevitt M, Schwartz AV, et al. The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. Journals of Gerontology Series A-Biological Sciences & Medical Sciences 2006;61(10):1059-64.
81. Kwan M, Woo J, Kwok T. The standard oxygen consumption value equivalent to one metabolic equivalent (3.5 ml/min/kg) is not appropriate for elderly people. International Journal of Food Sciences & Nutrition 2004;55(3):179-82.
82. Krems C, Luhrmann PM, Strassburg A, Hartmann B, Neuhauser-Berthold M. Lower resting metabolic rate in the elderly may not be entirely due to changes in body composition. European Journal of Clinical Nutrition 2005;59(2):255-62.
83. Tyagi R, Kapoor S, Kapoor AK. Body composition and fat distribution pattern of urban elderly females, Delhi, India. Collegium Antropologicum 2005;29(2):493-8.
84. Tanko LB, Bagger YZ, Alexandersen P, Larsen PJ, Christiansen C. Peripheral adiposity exhibits an independent dominant antiatherogenic effect in elderly women.[see comment]. Circulation 2003;107(12):1626-31.
85. Ding J, Kritchevsky SB, Newman AB, Taaffe DR, Nicklas BJ, Visser M, et al. Effects of birth cohort and age on body composition in a sample of community-based elderly. American Journal of Clinical Nutrition 2007;85(2):405-10.
86. Sanchez-Garcia S, Garcia-Pena C, Duque-Lopez MX, Juarez-Cedillo T, Cortes-Nunez AR, Reyes-Beaman S. Anthropometric, measures and nutritional status in a healthy elderly population. BMC Public Health 2007;7:2.
87. Goodpaster BH, Brown NF. Skeletal muscle lipid and its association with insulin resistance: what is the role for exercise? Exercise & Sport Sciences Reviews 2005;33(3):150-4.
88. Zamboni M, Zoico E, Fantin F, Panourgia MP, Di Francesco V, Tosoni P, et al. Relation between leptin and the metabolic syndrome in elderly women. Journals of Gerontology Series A-Biological Sciences & Medical Sciences 2004;59(4):396-400.
89. Crabbe P, Goemaere S, Zmierczak H, Van Pottelbergh I, De Bacquer D, Kaufman JM. Are serum leptin and the Gln223Arg polymorphism of the leptin receptor determinants of bone homeostasis in elderly men? European Journal of Endocrinology 2006;154(5):707-14.
90. Norata GD, Ongari M, Garlaschelli K, Raselli S, Grigore L, Catapano AL. Plasma resistin levels correlate with determinants of the metabolic syndrome. European Journal of Endocrinology 2007;156(2):279-84.
91. Schutte AE, Huisman HW, Schutte R, van Rooyen JM, Malan L, Malan NT. Aging influences the level and functions of fasting plasma ghrelin levels: the POWIRS-Study. Regulatory Peptides 2007;139(1-3):65-71.
92. Zoico E, Di Francesco V, Mazzali G, Vettor R, Fantin F, Bissoli L, et al. Adipocytokines, fat distribution, and insulin resistance in elderly men and women. Journals of Gerontology Series A-Biological Sciences & Medical Sciences 2004;59(9):M935-9.
93. Gannage-Yared M-H, Khalife S, Semaan M, Fares F, Jambart S, Halaby G. Serum adiponectin and leptin levels in relation to the metabolic syndrome, androgenic profile and somatotropic axis in healthy non-diabetic elderly men. European Journal of Endocrinology 2006;155(1):167-76.
94. Bik W, Baranowska-Bik A, Wolinska-Witort E, Martynska L, Chmielowska M, Szybinska A, et al. The relationship between adiponectin levels and metabolic status in centenarian, early elderly, young and obese women. Neuroendocrinology Letters 2006;27(4):493-500.
95. Frystyk J, Berne C, Berglund L, Jensevik K, Flyvbjerg A, Zethelius B. Serum adiponectin is a predictor of coronary heart disease: a population-based 10-year follow-up study in elderly men. Journal of Clinical Endocrinology & Metabolism 2007;92(2):571-6.
96. Laughlin GA, Barrett-Connor E, May S, Langenberg C. Association of adiponectin with coronary heart disease and mortality: the Rancho Bernardo study. American Journal of Epidemiology 2007;165(2):164-74.
97. Fatouros IG, Tournis S, Leontsini D, Jamurtas AZ, Sxina M, Thomakos P, et al. Leptin and adiponectin responses in overweight inactive elderly following resistance training and detraining are intensity related. Journal of Clinical Endocrinology & Metabolism 2005;90(11):5970-7.
98. Schrager MA, Metter EJ, Simonsick E, Ble A, Bandinelli S, Lauretani F, et al. Sarcopenic obesity and inflammation in the InCHIANTI study. Journal of Applied Physiology 2007;102(3):919-25.
99. Hoekstra T, Geleijnse JM, Schouten EG, Kok FJ, Kluft C. Relationship of C-reactive protein with components of the metabolic syndrome in normal-weight and overweight elderly. Nutrition Metabolism & Cardiovascular Diseases 2005;15(4):270-8.
100. Figaro MK, Kritchevsky SB, Resnick HE, Shorr RI, Butler J, Shintani A, et al. Diabetes, inflammation, and functional decline in older adults: findings from the Health, Aging and Body Composition (ABC) study. Diabetes Care 2006;29(9):2039-45.
101. Penninx BWJH, Kritchevsky SB, Newman AB, Nicklas BJ, Simonsick EM, Rubin S, et al. Inflammatory markers and incident mobility limitation in the elderly. Journal of the American Geriatrics Society 2004;52(7):1105-13.
102. Jenny NS, Yanez ND, Psaty BM, Kuller LH, Hirsch CH, Tracy RP. Inflammation biomarkers and near-term death in older men. American Journal of Epidemiology 2007;165(6):684-95.
103. Sipila S. Body composition and muscle performance during menopause and hormone replacement therapy. Journal of Endocrinological Investigation 2003;26(9):893-901.
104. Augoulea A, Mastorakos G, Lambrinoudaki I, Christodoulakos G, Creatsas G. Role of postmenopausal hormone replacement therapy on body fat gain and leptin levels. Gynecological Endocrinology 2005;20(4):227-35.
105. Sowers M, Zheng H, Tomey K, Karvonen-Gutierrez C, Jannausch M, Li X, et al. Changes in body composition in women over six years at midlife: ovarian and chronological aging. Journal of Clinical Endocrinology & Metabolism 2007;92(3):895-901.
106. Tufano A, Marzo P, Enrini R, Morricone L, Caviezel F, Ambrosi B. Anthropometric, hormonal and biochemical differences in lean and obese women before and after menopause. Journal of Endocrinological Investigation 2004;27(7):648-53.
107. Morita Y, Iwamoto I, Mizuma N, Kuwahata T, Matsuo T, Yoshinaga M, et al. Precedence of the shift of body-fat distribution over the change in body composition after menopause. Journal of Obstetrics & Gynaecology Research 2006;32(5):513-6.
108. Li S, Wagner R, Holm K, Lehotsky J, Zinaman MJ. Relationship between soft tissue body composition and bone mass in perimenopausal women. Maturitas 2004;47(2):99-105.
109. Bagger YZ, Tanko LB, Alexandersen P, Qin G, Christiansen C. The implications of body fat mass and fat distribution for cognitive function in elderly women. Obesity Research 2004;12(9):1519-26.
110. Yannakoulia M, Melistas L, Solomou E, Yiannakouris N. Association of eating frequency with body fatness in pre- and postmenopausal women. Obesity 2007;15(1):100-6.
111. Chen Z, Bassford T, Green SB, Cauley JA, Jackson RD, LaCroix AZ, et al. Postmenopausal hormone therapy and body composition - a substudy of the estrogen plus progestin trial of the Women's Health Initiative. American Journal of Clinical Nutrition 2005;82(3):651-6.
112. Maddalozzo GF, Cardinal BJ, Li F, Snow CM. The association between hormone therapy use and changes in strength and body composition in early postmenopausal women. Menopause 2004;11(4):438-46.
113. Sites CK, L'Hommedieu GD, Toth MJ, Brochu M, Cooper BC, Fairhurst PA. The effect of hormone replacement therapy on body composition, body fat distribution, and insulin sensitivity in menopausal women: a randomized, double-blind, placebo-controlled trial. Journal of Clinical Endocrinology & Metabolism 2005;90(5):2701-7.
114. Goodrow GJ, L'Hommedieu GD, Gannon B, Sites CK. Predictors of worsening insulin sensitivity in postmenopausal women. American Journal of Obstetrics & Gynecology 2006;194(2):355-61.
115. Allan CA, Strauss BJ, Burger HG, Forbes EA, McLachlan RI. The association between obesity and the diagnosis of androgen deficiency in symptomatic ageing men. Medical Journal of Australia 2006;185(8):424-7.
116. Travison TG, Araujo AB, O'Donnell AB, Kupelian V, McKinlay JB. A population-level decline in serum testosterone levels in American men.[see comment]. Journal of Clinical Endocrinology & Metabolism 2007;92(1):196-202.
117. Derby CA, Zilber S, Brambilla D, Morales KH, McKinlay JB. Body mass index, waist circumference and waist to hip ratio and change in sex steroid hormones: the Massachusetts Male Ageing Study. Clinical Endocrinology 2006;65(1):125-31.
118. Chen RYT, Wittert GA, Andrews GR. Relative androgen deficiency in relation to obesity and metabolic status in older men. Diabetes, Obesity & Metabolism 2006;8(4):429-35.
119. Maggio M, Lauretani F, Ceda GP, Bandinelli S, Basaria S, Ble A, et al. Association between hormones and metabolic syndrome in older Italian men. Journal of the American Geriatrics Society 2006;54(12):1832-8.
120. Laughlin GA, Barrett-Connor E, May S. Sex-specific association of the androgen to oestrogen ratio with adipocytokine levels in older adults: the Rancho Bernardo Study. Clinical Endocrinology 2006;65(4):506-13.
121. Carraro R, Ruiz-Torres A. Relationship of serum leptin concentration with age, gender, and biomedical parameters in healthy, non-obese subjects. Archives of Gerontology & Geriatrics 2006;43(3):301-12.
122. Zamboni M, Zoico E, Scartezzini T, Mazzali G, Tosoni P, Zivelonghi A, et al. Body composition changes in stable-weight elderly subjects: the effect of sex. Aging-Clinical & Experimental Research 2003; 15(4):321-7.
123. Muller M, Grobbee DE, den Tonkelaar I, Lamberts SWJ, van der Schouw YT. Endogenous sex hormones and metabolic syndrome in aging men.[see comment]. Journal of Clinical Endocrinology & Metabolism 2005;90(5):2618-23.
124. Cappola AR, Ratcliffe SJ, Bhasin S, Blackman MR, Cauley J, Robbins J, et al. Determinants of serum total and free testosterone levels in women over the age of 65 years. Journal of Clinical Endocrinology & Metabolism 2007;92(2):509-16.
125. Santoro N, Torrens J, Crawford S, Allsworth JE, Finkelstein JS, Gold EB, et al. Correlates of circulating androgens in mid-life women: the study of women's health across the nation.[see comment]. Journal of Clinical Endocrinology & Metabolism 2005;90(8):4836-45.
126. McTiernan A, Wu L, Chen C, Chlebowski R, Mossavar-Rahmani Y, Modugno F, et al. Relation of BMI and physical activity to sex hormones in postmenopausal women. Obesity 2006;14(9):1662-77.
127. Maggio M, Lauretani F, Ceda GP, Bandinelli S, Basaria S, Paolisso G, et al. Association of hormonal dysregulation with metabolic syndrome in older women: data from the InCHIANTI study. American Journal of Physiology - Endocrinology & Metabolism 2007;292(1):E353-8.
128. Gould DC, Kirby RS, Amoroso P. Hypoandrogen-metabolic syndrome: a potentially common and underdiagnosed condition in men. International Journal of Clinical Practice 2007;61(2):341-4.
129. Nair KS, Rizza RA, O'Brien P, Dhatariya K, Short KR, Nehra A, et al. DHEA in elderly women and DHEA or testosterone in elderly men.[see comment]. New England Journal of Medicine 2006;355(16):1647-59.
130. Kaufman JM, Vermeulen A. The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocrine Reviews 2005;26(6):833-76.
131. Lapauw B, Goemaere S, Crabbe P, Kaufman JM, Ruige JB. Is the effect of testosterone on body composition modulated by the androgen receptor gene CAG repeat polymorphism in elderly men? European Journal of Endocrinology 2007;156(3):395-401.
132. Katznelson L, Robinson MW, Coyle CL, Lee H, Farrell CE. Effects of modest testosterone supplementation and exercise for 12 weeks on body composition and quality of life in elderly men. European Journal of Endocrinology 2006;155(6):867-75.
133. Huang X, Blackman MR, Herreman K, Pabst KM, Harman SM, Caballero B. Effects of growth hormone and/or sex steroid administration on wbole-body protein turnover in healthy aged women and men. Metabolism: Clinical & Experimental 2005;54(9):1162-7.
134. Giannoulis MG, Jackson N, Shojaee-Moradie F, Sonksen PH, Martin FC, Umpleby AM. Effects of growth hormone and/or testosterone on very low density lipoprotein apolipoprotein B100 kinetics and plasma lipids in healthy elderly men: a randomised controlled trial. Growth Hormone & Igf Research 2006;16(5-6):308-17.
135. Villareal DT, Holloszy JO. DHEA enhances effects of weight training on muscle mass and strength in elderly women and men. American Journal of Physiology - Endocrinology & Metabolism 2006,291(5):E1003-8.
136. Leng SX, Cappola AR, Andersen RE, Blackman MR, Koenig K, Blair M, et al. Serum levels of insulin-like growth factor-I (IGF-I) and dehydroepiandrosterone sulfate (DHEA-S), and their relationships with serum interleukin-6, in the geriatric syndrome of frailty. Aging-Clinical & Experimental Research 2004;16(2):153-7.
137. Basu R, Man CD, Campioni M, Basu A, Nair KS, Jensen MD, et al. Two years of treatment with dehydroepiandrosterone does not improve insulin secretion, insulin action, or postprandial glucose turnover in elderly men or women. Diabetes 2007;56(3):753-66.
138. Kalme T, Seppala M, Qiao Q, Koistinen R, Nissinen A, Harrela M, et al. Sex hormone-binding globulin and insulin-like growth factor-binding protein-1 as indicators of metabolic syndrome, cardiovascular risk, and mortality in elderly men. Journal of Clinical Endocrinology & Metabolism 2005;90(3):1550-6.
139. Kupelian V, Page ST, Araujo AB, Travison TG, Bremner WJ, McKinlay JB. Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men. Journal of Clinical Endocrinology & Metabolism 2006;91(3):843-50.
140. Cikim AS, Ozbey N, Sencer E, Molvalilar S, Orhan Y. Associations among sex hormone binding globulin concentrations and characteristics of the metabolic syndrome in obese women. Diabetes, Nutrition & Metabolism - Clinical & Experimental 2004;17(5):290-5.
141. Chen M-J, Yang W-S, Yang J-H, Hsiao CK, Yang Y-S, Ho H-N. Low sex hormone-binding globulin is associated with low high-density lipoprotein cholesterol and metabolic syndrome in women with PCOS. Human Reproduction 2006;21(9):2266-71.
142. Weinberg ME, Manson JE, Baring JE, Cook NR, Seely EW, Ridker PM, et al. Low sex hormone-binding globulin is associated with the metabolic syndrome in postmenopausal women. Metabolism: Clinical & Experimental 2006;55(11):1473-80.
143. Heald AH, Anderson SG, Ivison F, Riste L, Laing I, Cruickshank JK, et al. Low sex hormone binding globulin is a potential marker for the metabolic syndrome in different ethnic groups. Experimental & Clinical Endocrinology & Diabetes 2005;113(9):522-8.
144. Sutton-Tyrrell K, Wildman RP, Matthews KA, Chae C, Lasley BL, Brockwell S, et al. Sex-hormone-binding globulin and the free androgen index are related to cardiovascular risk factors in multiethnic premenopausal and perimenopausal women enrolled in the Study of Women Across the Nation (SWAN). Circulation 2005;111(10):1242-9.
145. Xita N, Tsatsoulis A, Chatzikyriakidou A, Georgiou I. Association of the (TAAAA)n repeat polymorphism in the sex hormone-binding globulin (SHBG) gene with polycystic ovary syndrome and relation to SHBG serum levels. Journal of Clinical Endocrinology & Metabolism 2003;88(12):5976-80.
146. Mousavinasab F, Tahtinen T, Jokelainen J, Koskela P, Vanhala M. Oikarinen J, et al. The Pro12Ala polymorphism of the PPAR gamma 2 gene influences sex hormone-binding globulin level and its relationship to the development of the metabolic syndrome in young Finnish men. Endocrine 2006;30(2):185-90.
147. Toogood AA. The somatopause: an indication for growth hormone therapy? Treatments in Endocrinology 2004;3(4):201-9.
148. Lombardi G, Tauchmanova L, Di Somma C, Musella T, Rota F, Savanelli MC, et al. Somatopause: dismetabolic and bone effects. Journal of Endocrinological Investigation 2005;28(10 Suppl):36-42.
149. Liu H, Bravata DM, Olkin I, Nayak S, Roberts B, Garber AM, et al. Systematic review: the safety and efficacy of growth hormone in the healthy elderly. Annals of Internal Medicine 2007;146(2):104-15.
150. Gotherstrom G, Bengtsson B-A, Sunnerhagen KS, Johannsson G, Svensson J. The effects of five-year growth hormone replacement therapy on muscle strength in elderly hypopituitary patients. Clinical Endocrinology 2005;62(1):105-13.
151. Arwert LI, Veltman DJ, Deijen JB, Lammertsma AA, Jorker C, Drent ML. Memory performance and the growth hormone/insulin-like growth factor axis in elderly: a positron emission tomography study. Neuroendocrinology 2005;81(1):31-40.
152. Arwert LI, Veltman DJ, Deijen JB, van Dam PS, Drent ML. Effects of growth hormone substitution therapy on cognitive functioning in growth hormone deficient patients: a functional MRI study. Neuroendocrinology 2006;83(1):12-9.
153. Arwert LI, Deijen JB, Drent ML. The relation between insulin-like growth factor I levels and cognition in healthy elderly: a meta-analysis. Growth Hormone & Igf Research 2005;15(6):416-22.
154. Kok P, Roelfsema F, Frolich M, Meinders AE, Pijl H. Prolactin release is enhanced in proportion to excess visceral fat in obese women. Journal of Clinical Endocrinology & Metabolism 2004;89(9):4445-9.
155. Tuzcu A, Bahceci M, Dursun M, Turgut C, Bahceci S. Insulin sensitivity and hyperprolactinemia. Journal of Endocrinological Investigation 2003;26(4):341-6.
156. Nilsson L, Binart N, Bohlooly-Y M, Bramnert M, Egecioglu E, Kindblom J, et al. Prolactin and growth hormone regulate adiponectin secretion and receptor expression in adipose tissue. Biochemical & Biophysical Research Communications 2005;331(4):1120-6.
157. Asai-Sato M, Okamoto M, Endo M, Yoshida H, Murase M, Ikeda M, et al. Hypoadiponectinemia in lean lactating women: Prolactin inhibits adiponectin secretion from human adipocytes. Endocrine Journal 2006;53(4):555-62.
158. Wallaschofski H, Kobsar A, Sokolova O, Siegemund A, Stepan H, Faber R, et al. Differences in platelet activation by prolactin and leptin. Hormone & Metabolic Research 2004;36(7):453-7.
159. Serri O, Li L, Mamputu J-C, Beauchamp M-C, Maingrette F, Renier G. The influences of hyperprolactinemia and obesity on cardiovascular risk markers: effects of cabergoline therapy. Clinical Endocrinology 2006;64(4):366-70.
160. Kok P, Roelfsema F, Langendonk JG, de Wit CC, Frolich M, Burggraaf J, et al. Increased circadian prolactin release is blunted after body weight loss in obese premenopausal women. American Journal of Physiology - Endocrinology & Metabolism 2006;290(2):E218-24.
161. Galluzzi F, Salti R, Stagi S, La Cauza F, Chiarelli F. Reversible weight gain and prolactin levels - long-term follow-up in childhood. Journal of Pediatric Endocrinology 2005;18(9):921-4.
162. van den Beld AW, Visser TJ, Feelders RA, Grobbee DE, Lamberts SWJ. Thyroid hormone concentrations, disease, physical function, and mortality in elderly men.[see comment]. Journal of Clinical Endocrinology & Metabolism 2005;90(12):6403-9.
163. Katz R, Wong ND, Kronmal R, Takasu J, Shavelle DM, Probstfield JL, et al. Features of the metabolic syndrome and diabetes mellitus as predictors of aortic valve calcification in the Multi-Ethnic Study of Atherosclerosis. Circulation 2006;113(17):2113-9.
164. Purnell JQ, Brandon DD, Isabelle LM, Loriaux DL, Samuels MH. Association of 24-hour cortisol production rates, cortisol-binding globulin, and plasma-free cortisol levels with body composition, leptin levels, and aging in adult men and women. Journal of Clinical Endocrinology & Metabolism 2004;89(1):281-7.
165. Walker BR. Cortisol--cause and cure for metabolic syndrome? Diabetic Medicine 2006;23(12):1281-8.
166. Chiodini I, Adda G, Scillitani A, Coletti F, Morelli V, Di Lembo S, et al. Cortisol secretion in patients with type 2 diabetes: relationship with chronic complications. Diabetes Care 2007;30(1):83-8.
167. Fiocco AJ, Wan N, Weekes N, Pim H, Lupien SJ. Diurnal cycle of salivary cortisol in older adult men and women with subjective complaints of memory deficits and/or depressive symptoms: relation to cognitive functioning. Stress 2006;9(3):143-52.
168. Csemansky JG, Dong H, Fagan AM, Wang L, Xiong C, Holtzman DM, et al. Plasma cortisol and progression of dementia in subjects with Alzheimer-type dementia. American Journal of Psychiatry 2006;163(12):2164-9.
169. Tomlinson JW, Sherlock M, Hughes B, Hughes SV, Kilvington F, Bartlett W, et al. Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 activity in vivo limits glucocorticoid exposure to human adipose tissue and decreases lipolysis. Journal of Clinical Endocrinology & Metabolism 2007;92(3):857-64.
170. Walker BR. Extra-adrenal regeneration of glucocorticoids by 11beta-hydroxysteroid dehydrogenase type 1: physiological regulator and pharmacological target for energy partitioning. Proceedings of the Nutrition Society 2007;66(1):1-8.
171. Brach JS, Simonsick EM, Kritchevsky S, Yaffe K, Newman AB, Health AaBCSRG. The association between physical function and lifestyle activity and exercise in the health, aging and body composition study. Journal of the American Geriatrics Society 2004;52(4):502-9.
172. Di Francesco V, Zamboni M, Zoico E, Bortolani A, Maggi S, Bissoli L, et al. Relationships between leisure-time physical activity, obesity and disability in elderly men. Aging-Clinical & Experimental Research 2005;17(3):201-6.
173. Rimbert V, Montaurier C, Bedu M, Boirie Y, Morio B. Behavioral and physiological regulation of body fatness: a cross-sectional study in elderly men. International Journal of Obesity 2006;30(2):322-30.
174. Raguso CA, Kyle U, Kossovsky MP, Roynette C, Paotoni-Giacobino A, Hans D, et al. A 3-year longitudinal study on body composition changes in the elderly: role of physical exercise. Clinical Nutrition 2006;25(4):573-80.
175. Kim HJ, Lee JS, Kim CK. Effect of exercise training on muscle glucose transporter 4 protein and intramuscular lipid content in elderly men with impaired glucose tolerance. European Journal of Applied Physiology 2004;93(3):353-8.
176. Fatouros IG, Kambas A, Katrabasas I, Leontsini D, Chatzinikolaou A, Jamurtas AZ, et al. Resistance training and detraining effects on flexibility performance in the elderly are intensity-dependent. Journal of Strength & Conditioning Research 2006;20(3):634-42.
177. Bautmans I, Njemini R, Vasseur S, Chabert H, Moens L, Demanet C, et al. Biochemical changes in response to intensive resistance exercise training in the elderly. Gerontology 2005;51(4):253-65.
178. Vincent HK, Bourguignon C, Vincent KR. Resistance training lowers exercise-induced oxidative stress and homocysteine levels in overweight and obese older adults. Obesity 2006;14(11):1921-30.
179. Villareal DT, Miller BV, 3rd, Banks M, Fontana L, Sinacore DR, Klein S. Effect of lifestyle intervention on metabolic coronary heart disease risk factors in obese older adults.[see comment]. American Journal of Clinical Nutrition 2006;84(6):1317-23.
180. Tsuzuku S, Kajioka T, Endo H, Abbott RD, Curb JD, Yano K. Favorable effects of non-instrumental resistance training on fat distribution and metabolic profiles in healthy elderly people. European Journal of Applied Physiology 2007;99(5):549-55.
181. Verney J, Kadi F, Saafi MA, Piehl-Aulin K, Denis C. Combined lower body endurance and upper body resistance training improves performance and health parameters in healthy active elderly. European Journal of Applied Physiology 2006;97(3):288-97.
182. Villareal DT, Banks M, Sinacore DR, Siener C, Klein S. Effect of weight loss and exercise on frailty in obese older adults. Archives of Internal Medicine 2006;166(8):860-6.
183. Weiss EP, Racette SB, Villareal DT, Fontana L, Steger-May K, Schechtman KB, et al. Improvements in glucose tolerance and insulin action induced by increasing energy expenditure or decreasing energy intake: a randomized controlled trial. American Journal of Clinical Nutrition 2006;84(5):1033-42.
184. Thomas GN, Hong AWL, Tomlinson B, Lau E, Lam CWK, Sanderson JE, et al. Effects of Tai Chi and resistance training on cardiovascular risk factors in elderly Chinese subjects: a 12-month longitudinal, randomized, controlled intervention study. Clinical Endocrinology 2005;63(6):663-9.
185. Coker RH, Hays NP, Williams RH, Brown AD, Freeling SA, Kortebein PM, et al. Exercise-induced changes in insulin action and glycogen metabolism in elderly adults. Medicine & Science in Sports & Exercise 2006;38(3):433-8.
186. Binder EF, Yarasheski KE, Steger-May K, Sinacore DR, Brown M, Schechtman KB, et al. Effects of progressive resistance training on body composition in frail older adults: results of a randomized, controlled trial. Journals of Gerontology Series A-Biological Sciences & Medical Sciences 2005;60(11):1425-31.
187. Evans EM, Racette SB, Peterson LR, Villareal DT, Greiwe JS, Holloszy JO. Aerobic power and insulin action improve in response to endurance exercise training in healthy 77-87 yr olds. Journal of Applied Physiology 2005;98(1):40-5.
188. Toraman NF, Ayceman N. Effects of six weeks of detraining on retention of functional fitness of old people after nine weeks of multicomponent training. British Journal of Sports Medicine 2005;39(8):565-8; discussion 568.
189. Tsourlou T, Benik A, Dipla K, Zafeiridis A, Kellis S. The effects of a twenty-four-week aquatic training program on muscular strength performance in healthy elderly women. Journal of Strength & Conditioning Research 2006;20(4):811-8.
190. Berke EM, Koepsell TD, Moudon AV, Hoskins RE, Larson EB. Association of the built environment with physical activity and obesity in older persons. American Journal of Public Health 2007;97(3):486-92.
191. Mazzali G, Di Francesco V, Zoico E, Fantin F, Zamboni O, Benati C, et al. Interrelations between fat distribution, muscle lipid content, adipocytokines, and insulin resistance: effect of moderate weight loss in older women. American Journal of Clinical Nutrition 2006;84(5):1193-9.
192. Wannamethee SG, Shaper AG, Whincup PH. Modifiable lifestyle factors and the metabolic syndrome in older men: Effects of lifestyle changes. Journal of the American Geriatrics Society 2006;54(12):1909-14.
193. Newman AB, Lee JS, Visser M, Goodpaster BH, Kritchevsky SB, Tylavsky FA, et al. Weight change and the conservation of lean mass in old age: the Health, Aging and Body Composition Study. American Journal of Clinical Nutrition 2005;82(4):872-8; quiz 915-6.
194. van Strien T, van de Laar FA, van Leeuwe JFJ, Lucassen PLBJ, van den Hoogen HJM, Rutten GEHM, et al. The dieting dilemma in patients with newly diagnosed type 2 diabetes: does dietary restraint predict weight gain 4 years after diagnosis? Health Psychology 2007;26(1):105-12.
195. Rideout CA, Linden W, Barr SI. High cognitive dietary restraint is associated with increased cortisol excretion in postmenopausal women. Journals of Gerontology Series A-Biological Sciences & Medical Sciences 2006;61(6):628-33.
196. Phillips SM, Hartman JW, Wilkinson SB. Dietary protein to support anabolism with resistance exercise in young men. Journal of the American College of Nutrition 2005;24(2):134S-139S.
197. Evans WJ. Protein nutrition, exercise and aging. Journal of the American College of Nutrition 2004;23(6 Suppl):601S-609S.
198. Guillet C, Zangarelli A, Gachon P, Morio B, Giraudet C, Rousset P, et al. Whole body protein breakdown is less inhibited by insulin, but still responsive to amino acid, in nondiabetic elderly subjects. Journal of Clinical Endocrinology & Metabolism 2004;89(12):6017-24.
199. Flakoll P, Sharp R, Baier S, Levenhagen D, Carr C, Nissen S. Effect of beta-hydroxy-beta-methylbutyrate, arginine, and lysine supplementation on strength, functionality, body composition, and protein metabolism in elderly women. Nutrition 2004;20(5):445-51.
200. Tidermark J, Ponzer S, Carlsson P, Soderqvist A, Brismar K, Tengstrand B, et al. Effects of protein-rich supplementation and nandrolone in lean elderly women with femoral neck fractures. Clinical Nutrition 2004;23(4):587-96.
201. Bartali B, Semba RD, Frongillo EA, Varadhan R, Ricks MO, Blaum CS, et al. Low micronutrient levels as a predictor of incident disability in older women. Archives of Internal Medicine 2006;166(21):2335-40.
202. Hofbauer KG, Nicholson JR, Boss O. The obesity epidemic: current and future pharmacological treatments. Annual Review of Pharmacology & Toxicology 2007;47:565-92.
203. Carter CS, Onder G, Kritchevsky SB, Pahor M. Angiotensin-converting enzyme inhibition intervention in elderly persons: effects on body composition and physical performance. Journals of Gerontology Series A-Biological Sciences & Medical Sciences 2005;60(11):1437-46.
204. Cesari M, Kritchevsky SB, Baumgartner RN, Atkinson HH, Penninx BWHJ, Lenchik L, et al. Sarcopenia, obesity, and inflammation - results from the Trial of Angiotensin Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors study. American Journal of Clinical Nutrition 2005;82(2):428-34.
205. Gillies CL, Abrams KR, Lambert PC, Cooper NJ, Sutton AJ, Hsu RT, et al. Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis. BMJ 2007;334(7588):299.
206. Richelsen B, Tonstad S, Rossner S, Toubro S, Niskanen L, Madsbad S, et al. Effect of orlistat on weight regain and cardiovascular risk factors following a very-low-energy diet in abdominally obese patients: a 3-year randomized, placebo-controlled study. Diabetes Care 2007;30(1):27-32.
207. Bougoulia M, Triantos A, Koliakos G. Effect of weight loss with or without orlistat treatment on adipocytokines, inflammation, and oxidative markers in obese women. Hormones 2006;5(4):259-69.
208. Zelber-Sagi S, Kessler A, Brazowsky E, Webb M, Lurie Y, Santo M, et al. A double-blind randomized placebo-controlled trial of orlistat for the treatment of nonalcoholic fatty liver disease. Clinical Gastroenterology & Hepatology 2006;4(5):639-44.
209. Arterburn DE, Crane PK, Veenstra DL. The efficacy and safety of sibutramine for weight loss: a systematic review. Archives of Internal Medicine 2004;164(9):994-1003.
210. Gursoy A, Erdogan MF, Cin MO, Cesur M, Baskal N. Comparison of orlistat and sibutramine in an obesity management program: efficacy, compliance, and weight regain after noncompliance. Eating & Weight Disorders: EWD 2006;11(4):e127-32.
211. Scholze J, Grimm E, Herrmann D, Unger T, Kintscher U. Optimal treatment of obesity-related hypertension: the Hypertension-Obesity-Sibutramine (HOS) study.[see comment]. Circulation 2007;115(15):1991-8.
212. Di Francesco V, Sacco T, Zamboni M, Bissoli L, Zoico E, Mazzah G, et al. Weight loss and quality of life improvement in obese subjects treated with sibutramine: a double-blind randomized multicenter study. Annals of Nutrition & Metabolism 2007;51(1):75-81.
213. Yee BJ, Phillips CL, Banerjee D, Caterson I, Hedner JA, Grunstein RR. The effect of sibutramine-assisted weight loss in men with obstructive sleep apnoea. International Journal of Obesity 2007;31(1):161-8.
214. Van Gaul LF, Rissanen AM, Scheen AJ, Ziegler O, Rossner S, Group RI-ES. Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study.[see comment] [erratum appears in Lancet. 2005 Jul 30-Aug 5;366(9483):370]. Lancet 2005;365(9468):1389-97.
215. Pi-Sunyer FX, Aronne LJ, Heshmati HM, Devin J, Rosenstock J, Group RI-NAS. Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial.[see comment] [erratum appears in JAMA. 2006 Mar 15;295(11):1252]. JAMA 2006;295(7):761-75.
216. Despres J-P, Golay A, Sjostrom, L, Rimonabant in Obesity-Lipids Study G. Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia.[see comment]. New England Journal of Medicine 2005;353(20):2121-34.
217. Scheen AJ, Finer N, Hollander P, Jensen MD, Van Gaal LF, Group RI-DS. Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study.[see comment] [erratum appears in Lancet. 2006 Nov 11;368(9548):1650]. Lancet 2006;368(9548):1660-72.
218. Yan ZC, Liu DY, Zhang LL, Shen CY, Ma QL, Cao TB, et al. Exercise reduces adipose tissue via cannabinoid receptor type 1 which is regulated by peroxisome proliferator-activated receptor-delta. Biochemical & Biophysical Research Communications 2007;354(2):427-33.
219. Curioni C, Andre C. Rimonabant for overweight or obesity. Cochrane Database of Systematic Reviews 2006(4):CD006162.
220. O'Brien PE, Dixon JB, Laurie C, Skinner S, Proietto J, McNeil J, et al. Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or an intensive medical program: a randomized trial.[see comment] [summary for patients in Ann Intern Med. 2006 May 2;144(9):I12; PMID: 16670127]. Annals of Internal Medicine 2006;144(9):625-33.
221. Fatima J, Houghton SG, Iqbal CW, Thompson GB, Que FL, Kendrick ML, et al. Bariatric surgery at the extremes of age. Journal of Gastrointestinal Surgery 2006;10(10):1392-6.
222. Taylor CJ, Layani L. Laparoscopic adjustable gastric banding in patients > or =60 years old: is it worthwhile? Obesity Surgery 2006;16(12):1579-83.